This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: C. R. Bard, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Seth C Schneider in Female External Catheters
Introduction
Seth C Schneider is an accomplished inventor based in Social Circle, GA (US). He has made significant contributions to the field of medical devices, particularly in the development of female external catheters. His innovative approach has led to the creation of a patent that addresses the needs of female patients.
Latest Patents
Seth Schneider holds a patent for female external catheters and methods thereof. The patent describes a female external catheter (FEC) that includes a catheter body, a catheter back, and a connector. The catheter body features a cavity that extends along its length and is designed to open toward the patient. The catheter back includes a connector hole aligned with the end portion of the cavity, which opens away from the patient. The connector, situated in the connector hole, features a sump that collects urine from the cavity for withdrawal from the FEC. This innovative design enhances the usability and effectiveness of external catheters for women.
Career Highlights
Seth Schneider is associated with C. R. Bard, Inc., a company known for its advancements in medical technology. His work at the company has allowed him to focus on developing solutions that improve patient care and comfort. With a patent portfolio that includes 1 patent, Schneider has established himself as a key player in the medical device industry.
Collaborations
Throughout his career, Seth has collaborated with talented professionals, including D Claire Gloeckner and Matthew J Rothberg. These collaborations have contributed to the successful development of innovative medical solutions.
Conclusion
Seth C Schneider's contributions to the field of female external catheters demonstrate his commitment to improving healthcare solutions for women. His innovative designs and collaborative efforts continue to make a positive impact in the medical device industry.
